Catherine P. Schneider
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Catherine P. Schneider has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Alex Dunn
Stanford
1 shared publication- Alexander R. Dunn
Stanford University
1 shared publication Alicia L. Richards
1 shared publication- Andrew Dillin
Department of Molecular and Cell Biology, University of California, Berkeley, California, USA
1 shared publication Andrew S. Moore
1 shared publicationAshley E. Mason
University of California San Francisco
1 shared publication
Latest Publications
- Open Access
- 6 August 2020
- Published by Springer Nature in Research Square
Stringency in polycystic ovary syndrome (PCOS) criteria and application in clinical study recruitment
Background: In this manuscript, we review the various criteria used to diagnosis PCOS, and discuss how the specific diagnostic criteria used can impact recruitment for PCOS studies. PCOS is a common diagnosis, but with a number of differing definitions. We were interested in addressing these differing stringencies and application in clinical trial, such as our group’s PCOS diet study.Methods: For our study on the effects of diets to alter insulin resistance, we adopted the one using more stringent criteria, consisting of biochemical abnormalities, menstrual abnormalities, insulin resistance and abnormal ovarian size and structure. Our study actively recruits from PCOS clinics in the Bay Area. We reported number of women successfully recruited using our PCOS diagnosis stringency, and how these numbers differ from women referred to PCOS clinics in the Bay Area. We also report the reasons patients did not fit our diagnosis criteria to shed insight into how diagnosis differ between healthcare professionals.Results: To our surprise, the vast majority of subjects seen in the tertiary referral PCOS center at UCSF did not qualify for the study.Conclusion: The definition of PCOS may be important in study design, and can impact the ability to recruit for the study.Trial registration: Date of registration: June 20, 2014, NIH ClinicalTrials.gov identifier: NCT02190097
- 6 August 2020
- Published by Springer Nature in Research Square
Open AccessStringency in polycystic ovary syndrome (PCOS) criteria and application in clinical study recruitment
Background: In this manuscript, we review the various criteria used to diagnosis PCOS, and discuss how the specific diagnostic criteria used can impact recruitment for PCOS studies. PCOS is a common diagnosis, but with a number of differing definitions. We were interested in addressing these differing stringencies and application in clinical trial, such as our group’s PCOS diet study.Methods: For our study on the effects of diets to alter insulin resistance, we adopted the one using more stringent criteria, consisting of biochemical abnormalities, menstrual abnormalities, insulin resistance and abnormal ovarian size and structure. Our study actively recruits from PCOS clinics in the Bay Area. We reported number of women successfully recruited using our PCOS diagnosis stringency, and how these numbers differ from women referred to PCOS clinics in the Bay Area. We also report the reasons patients did not fit our diagnosis criteria to shed insight into how diagnosis differ between healthcare professionals.Results: To our surprise, the vast majority of subjects seen in the tertiary referral PCOS center at UCSF did not qualify for the study.Conclusion: The definition of PCOS may be important in study design, and can impact the ability to recruit for the study.Trial registration: Date of registration: June 20, 2014, NIH ClinicalTrials.gov identifier: NCT02190097
- Open Access
Adhesion-mediated mechanosignaling forces mitohormesis
Mitochondria control eukaryotic cell fate by producing the energy needed to support life and the signals required to execute programmed cell death. The biochemical milieu is known to affect mitochondrial function and contribute to the dysfunctional mitochondrial phenotypes implicated in cancer and the morbidities of ageing. However, the physical characteristics of the extracellular matrix are also altered in cancer and in aging tissues. We demonstrate that cells sense the physical properties of the extracellular matrix and activate a mitochondrial stress response that adaptively tunes mitochondrial function via SLC9A1-dependent ion exchange and HSF1-dependent transcription. Overall, our data indicate that adhesion-mediated mechanosignaling may play an unappreciated role in the altered mitochondrial functions observed in aging and cancer. Graphical
Open AccessAdhesion-mediated mechanosignaling forces mitohormesis
Mitochondria control eukaryotic cell fate by producing the energy needed to support life and the signals required to execute programmed cell death. The biochemical milieu is known to affect mitochondrial function and contribute to the dysfunctional mitochondrial phenotypes implicated in cancer and the morbidities of ageing. However, the physical characteristics of the extracellular matrix are also altered in cancer and in aging tissues. We demonstrate that cells sense the physical properties of the extracellular matrix and activate a mitochondrial stress response that adaptively tunes mitochondrial function via SLC9A1-dependent ion exchange and HSF1-dependent transcription. Overall, our data indicate that adhesion-mediated mechanosignaling may play an unappreciated role in the altered mitochondrial functions observed in aging and cancer. Graphical